Company intelligence / Profile preview

Medifine

Daejeon, Daejeon, South Korea

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Medifine is a South Korean medical device company specializing in the development and manufacture of aesthetic medicine products. The company is a leading provider of Polydioxanone (PDO) lifting threads, which are used in non-surgical face-lift procedures to stimulate collagen production and improve skin elasticity. In addition to lifting threads, Medifine produces hyaluronic acid fillers and other dermatological solutions aimed at the global anti-aging market. The company maintains a strong focus on R&D to enhance the safety and efficacy of its minimally invasive cosmetic treatments. Medifine exports its products to numerous countries, establishing a significant presence in the international aesthetic dermatology sector.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Medifine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medifine.

Explore the full profile